C-reactive protein point-of-care testing to guide antibiotic prescribing for respiratory tract infections

Carl Llor1,2,3

  • 1Primary Care Research Institute Jordi Gol (IDIAP), Barcelona, Spain.

Abstract

Insights

C-reactive protein (CRP) rapid testing in primary care can reduce unnecessary antibiotic prescriptions for respiratory tract infections (RTIs). This cost-effective tool aids clinical decisions, combating antimicrobial resistance by optimizing antibiotic use.

Area of Science:

  • Primary Care Medicine
  • Infectious Diseases
  • Clinical Diagnostics

Background:

  • Antimicrobial resistance is a significant global health threat, closely linked to antibiotic consumption.
  • The majority of antibiotic prescriptions are issued in primary care settings, often for viral respiratory tract infections (RTIs) where they are not indicated.

Purpose of the Study:

  • To review the evidence on the utility of C-reactive protein (CRP) rapid testing in primary care for managing patients with RTIs.
  • To assess the role of CRP testing in reducing unnecessary antibiotic prescribing and mitigating antimicrobial resistance.

Main Methods:

  • A comprehensive literature search and narrative review of studies on CRP rapid testing for RTIs in primary care.
  • Analysis of evidence up to April 2025, focusing on clinical utility and impact on antibiotic prescribing.

Main Results:

  • CRP rapid testing is an effective and cost-efficient method to decrease unnecessary antibiotic use for lower RTIs in primary care.
  • The test supports clinical decision-making, complementing patient history and examination to rule out serious infections.

Conclusions:

  • CRP rapid testing should be integrated into clinical guidelines for managing RTIs when antibiotic prescription is uncertain.
  • Implementation requires clear guidance, clinician training in communication, and consideration of delayed prescribing strategies to combat antimicrobial resistance effectively.